Hexarelin

Also known as: Examorelin

Brand names: Examorelin

Overview

Growth hormone optimization and cardiac protection

Hexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects independent of GH. However, chronic use leads to desensitization, reducing its effectiveness over time.

Mechanism of Action

Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation

Dosage Information

Parameter	Detail
Administration	Subcutaneous injection
Typical Dose	100-200mcg 2x daily (pulsed use recommended)
Frequency	Daily

Side Effects

Reported adverse effects from clinical data and post-market surveillance

Common Side Effects

Increased appetite

Cortisol elevation

Prolactin elevation

Water retention

Desensitization with chronic use

Serious Side Effects

Receptor desensitization

Elevated cortisol

Unknown long-term cardiac effects

!Contraindications

Do not use this peptide if any of the following apply

Active cancer
Pregnancy
Children
Cardiac arrhythmias

Clinical Evidence

Evidence Quality

Emerging

Clinical Trial Phase

Preclinical / Not submitted

View Key Study

Cost Comparison

Estimated monthly costs compared to similar peptides

Peptide	Monthly Cost	FDA Status
Hexarelin	$40 - $80/mo	Not submitted
MK-677	$50 - $100/mo	Phase 2
CJC-1295	$35 - $70/mo	Not submitted
Ipamorelin	$35 - $70/mo	Not submitted
GHRP-6	$35 - $70/mo	Not submitted

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.